Gain Therapeutics, Inc. — Investor Relations & Filings
Gain Therapeutics, Inc. is a clinical-stage biotechnology company that discovers and develops next-generation allosteric small molecule therapies. The company utilizes its proprietary Magellan™ drug discovery platform, which combines artificial intelligence with physics-based computational models to identify novel allosteric binding sites on disease-implicated proteins. This approach aims to modulate protein function to treat diseases that are currently undruggable. The company's lead candidate, GT-02287, is in Phase I clinical trials for the treatment of GBA-Parkinson’s disease. Gain's therapeutic pipeline targets neurodegenerative diseases, lysosomal storage disorders, and other conditions with high unmet medical needs.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 8-K | 2026-05-26 | English | |
| DEF 14A - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-04-28 | English | |
| 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | |
| 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | |
| 8-K - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-03-18 | English | |
| 8-K Filing | 2026-02-03 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
6 filings
| |||||
| 47063407 | FORM 8-K | 2026-05-26 | English | ||
| 38172661 | DEF 14A - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-04-28 | English | ||
| 33053358 | 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | ||
| 33053356 | 4 - Gain Therapeutics, Inc. (0001819411) (Issuer) | 2026-03-27 | English | ||
| 32975364 | 8-K - Gain Therapeutics, Inc. (0001819411) (Filer) | 2026-03-18 | English | ||
| 31868801 | 8-K Filing | 2026-02-03 | English | ||
|
2025
9 filings
| |||||
| 13280065 | FORM 8-K | 2025-12-18 | English | ||
| 13280066 | FORM S-8 | 2025-12-03 | English | ||
| 13280067 | FORM 8-K | 2025-11-28 | English | ||
| 13280068 | 424B5 | 2025-11-28 | English | ||
| 13280071 | 10-Q | 2025-11-12 | English | ||
| 13280070 | 8-K | 2025-11-12 | English | ||
| 13280069 | S-3/A | 2025-11-07 | English | ||
| 13280072 | FORM 8-K | 2025-10-14 | English | ||
| 13280073 | FORM 8-K | 2025-10-09 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Gain Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34440/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34440 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34440 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34440 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34440}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Gain Therapeutics, Inc. (id: 34440)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.